Shannon Woods
Gerontology · Southaven, MSNPI 1487072864
Payments from drug & device makers
Across 549 payments — averaging $26.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$3K
- AstraZeneca$2K
- GSK$2K
- Boehringer Ingelheim$1K
- Mylan Specialty L.p.$643
- Actelion Pharmaceuticals US, Inc.$601
- plus $5K from 31 others
What the payments were for
- Consulting fees$2,34016%
- Food & beverage$11,73782%
- Education$2061%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 47 | $3,380 |
| AstraZeneca(2 entities) | 57 | $1,774 |
| GSK | 96 | $1,698 |
| Boehringer Ingelheim | 58 | $1,216 |
| Mylan Specialty L.p. | 31 | $643 |
| Actelion Pharmaceuticals US, Inc. | 36 | $601 |
| Harmony Biosciences LLC | 24 | $591 |
| Mallinckrodt Hospital Products Inc. | 21 | $587 |
| Amgen | 30 | $396 |
| Regeneron Healthcare Solutions, Inc. | 15 | $374 |
| Jazz Pharmaceuticals Inc. | 17 | $369 |
| Genentech USA, Inc. | 19 | $331 |
| Insmed, Inc. | 7 | $268 |
| La Jolla Pharmaceutical Company | 13 | $267 |
| Merck | 8 | $247 |
| United Therapeutics Corporation | 9 | $240 |
| Bayer | 12 | $200 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $198 |
| Pulmonx Corporation | 1 | $147 |
| ZOLL Respicardia, Inc. | 2 | $141 |
| Gilead | 4 | $77 |
| Electromed, Inc. | 6 | $70 |
| Baxter Healthcare | 4 | $67 |
| Pharmacyclics LLC, An Abbvie Company | 3 | $61 |
| Advanced Respiratory, Inc | 4 | $61 |
| Ambu Inc. | 2 | $38 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $32 |
| Shionogi Inc | 1 | $29 |
| Viatris Specialty LLC | 1 | $27 |
| Teva Pharmaceuticals USA, Inc. | 2 | $26 |
| Astellas Pharma US Inc | 1 | $22 |
| Grifols USA, LLC | 1 | $21 |
| Philips North America LLC | 1 | $19 |
| Fisher & Paykel Healthcare Inc | 1 | $18 |
| Pfizer | 1 | $17 |
| Inspire Medical Systems, Inc. | 1 | $17 |
| Ionis Pharmaceuticals, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DUPIXENT$549
- TEZSPIRE$413
- AIRSUPRA$282
- BREZTRI$268
- OFEV$175
- FASENRA$163
- CHARTIS CATHETER$147
- ZEPHYR DELIVERY CATHETER$147
- ZEPHYR ENDOBRONCHIAL VALVE$147
- PULMONX CHARTIS TABLET CONSOLE$147
- TRELEGY ELLIPTA$125
- ACTHAR$125
- remede System$121
- WINREVAIR$113
- NUCALA$101
How this compares
$14,283 in reported general payments places this provider in the 95th percentile of 66 gerontology providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 287 | $243,742 |
| XolairOmalizumab | 22 | $88,436 |
| Breo ElliptaFluticasone/Vilanterol | 109 | $69,535 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 96 | $68,089 |
| NucalaMepolizumab | 14 | $60,703 |
| Dupixent PenDupilumab | 13 | $49,326 |
| Spiriva RespimatTiotropium Bromide | 47 | $30,813 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 47 | $30,595 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 43 | $27,442 |
| SymbicortBudesonide/Formoterol Fumarate | 55 | $15,484 |
| Spiriva HandihalerTiotropium Bromide | 19 | $11,580 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 323 | $9,729 |
| Advair HfaFluticasone Propion/Salmeterol | 21 | $8,901 |
| Incruse ElliptaUmeclidinium Bromide | 25 | $7,808 |
| Bevespi AerosphereGlycopyrrolate/Formoterol Fum | 16 | $6,609 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta, Nucala, Anoro Ellipta, Incruse Ellipta | $1,698 | $415,729498 claims |
| AstraZenecaBreztri Aerosphere, Symbicort, Bevespi Aerosphere | $1,774 | $90,183167 claims |
| Boehringer IngelheimSpiriva Respimat, Stiolto Respimat, Combivent Respimat | $1,216 | $63,984102 claims |
| MerckDulera | $247 | $6,03418 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 66 gerontology providers in Mississippi.
Other gerontology in Southaven
- Christopher GullySouthaven$1K
- Leigh van DevenderOxford$16K
- Justin ColeLaurel$14K
- Shavonne DoyleOxford$14K
- Meghan MillsTupelo$10K
- Daniel WelchJackson$8K
- Addie HolcombGulfport$7K
- Laura RogersGulfport$5K
- Alexandria TannerOcean Springs$5K
- Katlyn AmasonFlowood$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.